An ICD-Associated DAMP Gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma

BACKGROUND: While some lung adenocarcinoma (LUAD) patients benefit long-term from treatment with immune checkpoint inhibitors, the sad reality is that a considerable proportion of patients do not. The classification of the LUAD tumor microenvironment (TME) can be used to conceptually comprehend prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuxin, Li, Kexin, Liang, Shuang, Lou, Xiaoying, Li, Yiling, Xu, Danfei, Wu, Yue, Wang, Yuan, Cui, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230791/
https://www.ncbi.nlm.nih.gov/pubmed/37259066
http://dx.doi.org/10.1186/s12931-023-02443-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230791/
https://www.ncbi.nlm.nih.gov/pubmed/37259066
http://dx.doi.org/10.1186/s12931-023-02443-0

Ejemplares similares